Long – acting bronchodilators
Comparative efficacy of long-acting bronchodilators for COPD - a network meta-analysis
... alternative long-acting treat- ments available for COPD, clinicians are faced with an increasingly challenging choice regarding the optimal ...of long-acting bronchodilators in patients ...
18
Comparative efficacy of long-acting bronchodilators for COPD - a network meta-analysis
... alternative long-acting treat- ments available for COPD, clinicians are faced with an increasingly challenging choice regarding the optimal ...of long-acting bronchodilators in patients ...
18
Predicting treatable traits for long-acting bronchodilators in patients with stable COPD
... Dovepress Kang et al The therapeutic efficacy of long-acting bronchodilators in the treatment of stable COPD has been well established. 3 They increase forced expiratory volume in 1 second (FEV 1 ) ...
9
Effects of long-acting bronchodilators in COPD patients according to COPD severity and ICS use
... inhaled long-acting bronchodilators in terms of both bronchodilator effect and the clinical outcomes of dyspnoea and health status in different populations of patients with COPD, over a period of ...
10
How Do Dual Long-acting Bronchodilators Prevent Exacerbations of Chronic Obstructive Pulmonary Disease?
... that long-acting bronchodilators (LABDs) can reduce exacerbation rate and/or severity, and others have shown that combinations of long-acting β 2 -adrenergic agonists (LABAs) and ...
40
Assessing the clinical value of fast onset and sustained duration of action of long-acting bronchodilators for COPD
... of long-acting bronchodilators for COPD and consider whether the theoretical ‘ideal’ profile translates into practical and clinical advantages for ...used long-acting ...
11
Long-acting bronchodilators improve exercise capacity in COPD patients: a systematic review and meta-analysis
... of long-acting bronchodilators most studied in these fields; however, a trend in favor of LAMA was identifiable at least in terms of endurance ...
12
Long-acting bronchodilators with or without inhaled corticosteroids and 30-day readmission in patients hospitalized for COPD
... Abbreviations: LABDs, long-acting bronchodilators; ICSs, inhaled corticosteroids; ICU, intensive care unit; CCU, coronary care unit. We performed the following sensitivity analyses to explain the ...
10
The association between inhaled long-acting bronchodilators and less in-hospital care in newly-diagnosed COPD patients
... Inhaled long-acting bronchodilators were prescribed mostly in tertiary healthcare centres in this ...inhaled long-acting bronchodilators are recommended initially in patients ...
9
Impact of prior and concurrent medication on exacerbation risk with long-acting bronchodilators in chronic obstructive pulmonary disease: a post hoc analysis
... 27]. Long-acting bronchodilators also have the potential to impact mucus secretions and mucocilli- ary clearance, and may have impacts on airway smooth muscle growth and airway fibrosis as well as ...
11
Adherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroids
... symptoms. Bronchodilators are central to such a therapeutic ...main bronchodilators are β 2 -agonists, anticholinergics, theophylline and a combination of these ...inhaled bronchodilators are ...
9
Dual combination therapy versus long-acting bronchodilators alone for chronic obstructive pulmonary disease (COPD):A systematic review and network meta-analysis
... inhaled long-acting bronchodilators (beta2-agonist and anticholiner- gic), ipratropium/albuterol combination products, oral beta-agonists, ICS, leukotriene modifiers, inhaled nedocromil and cromolyn, ...
535
Dual combination therapy versus long-acting bronchodilators alone for chronic obstructive pulmonary disease (COPD) : A systematic review and network meta-analysis
... inhaled long-acting bronchodilators (beta2-agonist and anticholiner- gic), ipratropium/albuterol combination products, oral beta-agonists, ICS, leukotriene modifiers, inhaled nedocromil and cromolyn, ...
535
Major comorbidities lead to the risk of adverse cardiovascular events in chronic obstructive pulmonary disease patients using inhaled long-acting bronchodilators: a case-control study
... inhaled bronchodilators were regulated by guidelines and the data is based on retrospective chart ...inhaled bronchodilators does not imply cause and ...inhaled long-acting ...
10
<p>Relationship of inhaled long-acting bronchodilators with cardiovascular outcomes among patients with stable COPD: a meta-analysis and systematic review of 43 randomized trials</p>
... were long- term use of long-acting bronchodilators in patients with stable COPD, so the effects of exacerbation of COPD, short-acting bronchodilators, or short-term treatment on ...
10
Additive efficacy of short-acting bronchodilators on dynamic hyperinflation and exercise tolerance in stable COPD patients treated with long-acting bronchodilators
... short-acting bronchodilators can be problematic in clinical ...of long-term regular bronchodilator therapy with procaterol hydrochroride 27 and oxirtopium bromide 28 in stable COPD ...
34
Long-acting bronchodilators improve Health Related Quality of Life in patients with COPD
... those long-term studies ICS slowed the rate of decline in HRQoL, with an effect that appears linear, despite the fact that the magnitude of this benefit was relatively small (MID ...of bronchodilators on ...
16
Short Term Effects of Tiotropium on COPD Patients Treated with Long Acting Bronchodilators
... short- acting bronchodilator occurs in the majority of patients, approximately 100- 130 ml and this parameter is smaller than the threshold of 200 ml which is clinically considered significant ...
6
Differential pharmacology and clinical utility of long-acting bronchodilators in COPD – focus on olodaterol
... once-daily long-acting β 2 -agonist (LABA) designed with the aim of improving β 2 -adrenoreceptor selectivity and intrinsic ...olodaterol long-acting antimuscarinic antagonists other than ...
7
Fixed-dose combination inhalers compared to long-acting bronchodilators for COPD: a network meta-analysis
... Additional clinical studies including several head-to-head trials comparing LABA/LAMA and LABA/ICS combinations ( Donohue 2015 ; Singh 2015 ; Vogelmeier 2013 ; Vogelmeier 2015 ; Wedzicha[r] ...
14